Here's Why Fulcrum Therapeutics, Inc. (FULC) is Poised for a Turnaround After Losing 32.6% in 4 Weeks

finance
2022-10-21 13:35:05

Fulcrum Therapeutics, Inc. (FULC) has been on a downward spiral lately with significant selling pressure. After declining 32.6% over the past four weeks, the stock looks well positioned for a trend reversal as it is now in oversold territory and there is strong agreement
